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Leipzig, Heidelberg, Freiberg, and Jena, Germany, Aalborg, Denmark, and Boston, MassBackground: Prenatal and early postnatal exposures to
environmental factors are considered responsible for the
increasing prevalence of allergic diseases. Although there is
some evidence for allergy-promoting effects in children because
of exposure to plasticizers, such as phthalates, findings of
previous studies are inconsistent and lack mechanistic
information.
Objective: We investigated the effect of maternal phthalate
exposure on asthma development in subsequent generations and
their underlying mechanisms, including epigenetic alterations.
Methods: Phthalate metabolites were measured within the
prospective mother-child cohort Lifestyle and Environmental
Factors and Their Influence on Newborns Allergy Risk (LINA)
and correlated with asthma development in the children.
A murine transgenerational asthma model was used to identify
involved pathways.
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AHR: Airway hyperreactivity
Aza: 5-Aza-29-deoxycytidine
BBP: Butyl benzyl phthalate
DEG: Differentially expressed gene
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Fads1: Fatty acid desaturase 1
Fanca: Fanconi anemia complementation group A
Foxp3: Forkhead box p3
LINA: Lifestyle and Environmental Factors and Their Influence on
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Allergic asthma is caused by a TH2 cell–mediated immune
response to common environmental allergens and characterized
by airway inflammation with pulmonary eosinophilia, airway
hyperreactivity (AHR), and increased serum IgE levels.1
This inflammatory airway disease has a strong genetic
background, but also, a multitude of environmental trigger
factors have been described.2,3 Epidemiologic and experimental
studies demonstrated that exposure to environmental pollutants,
such as diesel exhaust particles or environmental tobacco smoke,
or chemicals, such as volatile organic compounds, can lead to
exacerbation of respiratory symptoms and asthma.4-7 In partic-
ular, the prenatal and early postnatal periods appear critical to
environmental exposures, probably interfering with the develop-
mental programming of the immune system and thereby altering
the disease risk in later life.8 Epigenetic changes, such asmodified
DNA methylation, have been described as mediators between
exposure and disease development.8,9 This has been shown for
allergy-preventing effects induced by upbringing in a farming
environment or exposure to microbial components, as well as
for asthma-promoting influences, such asmaternal exposure to to-
bacco smoke during pregnancy.9-11 These findings emphasize that
the developing immune system is especially susceptible to
perturbations by external factors.
Here, we focused on phthalates, a group of chemicals
commonly used as plasticizers in large quantities worldwide.
These chemicals are present in a wide range of consumer
products, such as cosmetics, plastics, floor coverings, building
materials, toys, and cleaning products.12,13 Human subjects are
exposed to phthalates mainly through ingestion or inhalation
throughout life, starting in utero.14,15 Although there is some
evidence of allergy-promoting effects in children by maternal
phthalate exposure, findings of previous studies are conflicting
regarding the effect direction, the investigated exposure
conditions, and their assessment.16-18 Furthermore, little is known
about the mechanisms of maternal phthalate exposure, leading to
an altered disease risk in children’s later life.
In the present study we report a significant association between
maternal urinary concentrations of the phthalate metabolite
mono-n-butyl phthalate (MnBP) and an increased asthma risk
in children of our prospective mother-child cohort Lifestyle and
Environmental Factors and Their Influence on Newborns Allergy
Risk (LINA).7 Using a murine transgenerational asthma model,
we demonstrate that maternal exposure to butyl benzyl phthalate
(BBP), a parent compound of MnBP, has a direct effect on
severity of allergic airway inflammation in the offspring,
observing an enhanced airway inflammation, even in the F2
generation. This asthma-promoting effect was mediated by
BBP-induced DNA hypermethylation, as shown by diminished
BBP effects after treating mice with a hypomethylation-
inducing compound and a subsequently reduced expression of
genes involved in the differentiation of TH2 cells, such as the
GATA-3 repressor zinc finger protein 1 (Zfpm1), offering an
explanation for the increased allergic immune response.METHODS
For more detailed information, please see the Methods section in this
article’s Online Repository at www.jacionline.org.LINA study design and sample collection
The LINA cohort study recruited 629 mother-child pairs between May
2006 and December 2008 in Leipzig, Germany, to investigate how
environmental factors in the prenatal and postnatal period influence immune
system development and the resulting disease risks.19-21Urine samples and sample preparation
Phthalate metabolite quantification was carried out for 540 early morning
maternal urine samples, as described previously.22Exposure to BBP and ovalbumin immunization
BALB/c mice were exposed to BBP (3 mg/mL) exclusively through
drinking water (custom-built glass bottles) for different time periods,
as described in detail in the Methods section in this article’s Online
Repository.Measurement of airway responsiveness
Lung resistance was measured by using invasive plethysmography in
response to inhaled methacholine, as described previously23-25 and in more
detail in the Methods section in this article’s Online Repository.Whole-genome bisulfite sequencing, differentially
methylated region calling, and annotation
Whole-genome bisulfite sequencing (WGBS) library construction and
sequencing was performed, as previously described,26 by applying a
tagmentation-based, ultralow-input library preparation protocol with a
quantity of 20 ng of input DNA. Sequencing and alignment (mm10) were
carried out, as described previously.27 Differentially methylated region
(DMR) calling was performed, as described earlier.27RNA sequencing
Total RNAwas isolated, and RNA sequencing was performed, as described
previously.28-30Mapping of DMRs to target genes
DMRs were mapped on gene bodies, promoters, and putative enhancers of
the differentially expressed genes (DEGs), as described in detail in the
Methods section in this article’s Online Repository.
FIG 1. Maternal phthalate exposure and children’s asthma and allergic sensitization. A and C, Maternal
urine MnBP concentrations (34th gestational week) for children with asthma until age 6 (Fig 1, A) and sensi-
tization against inhalant allergens (Fig 1, C) compared with control subjects (medians and interquartile
ranges). B and D, Frequency and risk (adjusted odds ratio per 100 ng/mg MnBP increase) for asthma (Fig
1, B) and sensitization against inhalant allergens (Fig 1, D) according to maternal MnBP concentrations
(high 5 greater than median).
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MassARRAYanalysis was performed, as described previously.27
Statistical analysis
Equal parameter distribution was tested by using x2 tests. Logistic
regression models were implemented, adjusting for known confounding
factors of lung disease or atopy in early childhood, to assess the contribution
of phthalate exposure on risk increase for asthma development or increased
IgE levels in the children.
Nonparametric tests were applied for all nonnormally distributed
parameters (eg, Mann-Whitney U test [MWU] and Spearman correlations).
All calculations were performed in STATISTICA software for Windows
(Version 10; Statsoft, Tulsa, Okla). Data were expressed as means 6 SEMs,
and P values of less than .05 were considered significant.
RESULTS
Association between maternal phthalate
metabolites and the development of allergic
asthma in children (LINA)
For the LINA mother-child study, 629 mother-child pairs were
recruited between 2006 and 2008. The 6-year follow-up investi-
gation included 420 (66.8%) of the families. Regarding asthmadevelopment, only physician-diagnosed asthma was considered
for this study. For 24 of the LINA children, an asthma diagnosis
was reported until the age of 6 years. General characteristics of the
study participants are shown in Table E1 in this article’s Online
Repository at www.jacionline.org. Apart from a slightly lower
number of tobacco smoke–exposed children participating until
the age of 6 years, there were no differences between the analyzed
subcohort (n 5 371) and the total LINA cohort (n 5 629).
The concentration of 10 phthalate metabolites was determined
in a total of 540 maternal urine samples of the 34th week of
gestation. However, only measurements of the 371 children who
participated in the study until age 6 were considered for our
analysis (see Table E2 in this article’s Online Repository at www.
jacionline.org). Interestingly, an increased risk of asthma
symptoms until age 6 was observed only in children frommothers
with increased urinary MnBP levels (Fig 1, A and B), whereas all
other metabolites showed no significant association (see Table E3
and E5 in this article’s Online Repository at www.jacionline.org).
In addition to the lung phenotype, high maternal MnBP
concentrations were also associated with a higher risk for
allergic sensitization against inhalant allergens in the children
FIG 2. Phthalate exposure and induction of an asthma-like phenotype.A,Damswere exposed to BBP during
pregnancy (prenatal) or until weaning when pups were 3 weeks old (perinatal exposure). B, Exposure of
adult mice to BBP started 1 week before the first allergen injection and was continued until the end of
the asthma induction protocol. C, Female F1 mice from exposed or control dams were mated with
unexposed male mice. i.n., Intranasal; i.p., intraperitoneal.
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Repository at www.jacionline.org).Prenatal and perinatal exposure to BBP increased
allergic airway inflammation in a murine asthma
model
Next to monobenzyl phthalate (MBzP), MnBP is the major
metabolite of BBP.31 To further investigate whether the observedincrease in asthma risk in the human study cohort might be
directly caused by maternal exposure to BBP, we used a
well-established transgenerational ovalbumin (OVA)–induced
asthma mouse model.10,23,32,33 During the exposure period,
BALB/c mice received 3 mg/mL BBP through drinking water, a
concentration relevant for human exposure. MnBP levels
measured in the urine of BBP-exposed dams (see Table E6 in
this article’s Online Repository at www.jacionline.org) were
comparable with those detected in highly exposed LINA mothers
FIG 3. Prenatal and perinatal exposure to BBP increases allergic airway inflammation in a murine asthma
model. Total cell numbers in bronchoalveolar lavage (BAL) fluid (A), airway inflammation examined by lung
histology (hematoxylin and eosin, magnification 3100; B) quantified by an investigator-independent com-
puter-based analysis (C), and lung resistance (D) were examined in offspring from BBP-exposed dams and
in BBP-exposed adult mice. Data are expressed as means 6 SEMs (n >_ 9 animals per group in the offspring
[from >_5 dams] and adult mice from 4 independent experiments). *P < .05.
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BBP during pregnancy (prenatal) or during pregnancy
and breast-feeding (perinatal) to analyze the effect of maternal
BBP exposure on allergic airway inflammation. Grown-up
offspring were then subjected to antigen sensitization without
being exposed further to BBP (Fig 2, A). In another
treatment regimen, adult mice were exposed to BBP starting
1 week before OVA sensitization until the end of the asthma
protocol (Fig 2, B).Although exposure of adult mice to BBP had no effect on the
asthma-like phenotype, prenatal and perinatal BBP exposure
significantly increased the number of eosinophils within the
bronchoalveolar lavage fluid compared with the offspring from
unexposed dams (Fig 3, A). Maternal BBP exposure led to
substantially more inflammatory infiltrates in the airways, as
demonstrated bymeans of histologic examination of hematoxylin
and eosin–stained lung sections (Fig 3, B), as confirmed bymeans
of software-based image analysis (Fig 3, C). Accordingly, AHR
FIG 4. Prenatal and perinatal exposure to BBP enhances allergen-specific IgE levels and TH2 cytokine
production. OVA-specific IgE serum levels (A) and cytokine production of restimulated splenocytes
(B) and lymph node cells (C) were analyzed in OVA-immunized offspring from BBP-exposed dams and in
BBP-exposed adult mice. Data are expressed as means 6 SEMs (n >_ 9 animals per group in the offspring
[from >_5 dams] and adult groups from 4 independent experiments). *P < .05 and **P < .01.
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BBP-exposed dams (Fig 3, D).
Furthermore, OVA-specific IgE levels were increased in
prenatally and perinatally exposed offspring compared with
control mice (Fig 4, A). Moreover, OVA-restimulated spleen
and lymph node cells from offspring of BBP-exposed dams
produced significantly higher amounts of the TH2 cytokines
IL-5 and IL-13, whereas there was no significant effect on the
TH1 cytokine IFN-g (Fig 4, B and C).
To evaluate which BBP metabolite promotes the occurrence
of an asthma-like phenotype, we perinatally exposed mice to
MnBP or MBzP and subsequently characterized the asthma
phenotype in the offspring. Interestingly, neither MnBP
nor MBzP significantly increased the allergic airway
inflammation (see Fig E1 in this article’s Online Repository at
www.jacionline.org).Maternal BBP exposure induces global
hypermethylation mediating the asthma-
promoting effect
Early environmental influences have been shown to perturb
epigenetic changes, such as DNA methylation, that mightcontribute to programming of disease risks.8 To evaluate whether
maternal (perinatal) BBP exposure alters the global DNA
methylation pattern in the F1 generation, we subjected
splenic CD41 T cells isolated from dams and their 3-week-old
offspring to WGBS. DMRs were called with a difference in the
methylation level of greater than 5% and a P value of less than
.05 between the exposed group (F0 or F1) versus nonexposed con-
trolmiceof the samegeneration (n53,median false discovery rate:
F0, 0.056; F1, 0.036).
Our data show that maternal BBP exposure induced global
DNA hypermethylation in the F0 generation (63% hypermethy-
lated regions among identified DMRs) and to an even higher
extent in the offspring (83%; Fig 5,A, data set 1). Similar to the F0
generation, hypermethylation in the F1 generation was not
restricted to any particular genomic region but occurred genome
wide (Fig 5, B).
One-week-old pups fromBBP-exposed damswere treated with
the DNA methyltransferase inhibitor 5-aza-29-deoxycytidine
(Aza) for 2 weeks until weaning to evaluate whether BBP-
induced hypermethylation is linked to the severe allergic airway
inflammation observed in the offspring.34 Treatment of the
offspring with Aza reversed enhanced airway inflammation
caused by maternal BBP exposure, as demonstrated by the
FIG 5. Maternal BBP exposure induces global hypermethylation, which mediates the asthma-promoting
effect. A, DMRs were called from dams and their offspring between the exposed (F0 or F1) and nonexposed
groups. B, Numbers of DMRs in different DNA regions of the F1 generation. C-G, Total cell numbers in
bronchoalveolar lavage (BAL) fluid (Fig 5, C), airway inflammation (Fig 5, D), lung resistance (Fig 5, E),
OVA-specific IgE levels (Fig 5, F), and cytokine production in spleen and lymph node cells (Fig 5, G) were
examined in offspring from BBP-exposed dams compared with F1 mice treated with the DNA
methyltransferase inhibitor Aza. Data are expressed as means 6 SEMs (n >_ 9 animals per group in the
offspring [from >_6 dams) from 6 independent experiments). *P < .05, OVA versus OVA 1 BBP. #P < .05,
OVA 1 BBP versus OVA 1 BBP 1 Aza.
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lavage fluid (Fig 5, C), diminished lung inflammation (Fig 5, D),
and attenuated OVA-specific lung resistance (Fig 5, E), reduced
IgE levels (Fig 5, F), and IL-5/IL-13 levels in splenocytes and
IL-4/IL-5 levels in lymph node cells (Fig 5, G). Aza treatment
of pups from unexposed dams had no effect on the asthma-like
phenotype in the offspring.BBP-induced hypermethylation leads to
downregulation of certain target genes
To characterize the functional consequences of BBP-induced
hypermethylation on transcription, we assessed gene expression
using RNA sequencing in CD41 T cells from 3-week-old offspring
alongsidewith ourWGBS analysis. At a false discovery rate of less
than 0.01, we detected 1138 differential expressed genes (DEGs) in
the offspring of BBP-exposed dams in comparison with those of
nonexposed mice. Treated versus nontreated mice clustered with
respect to their genome-wide RNA expression by means of
unsupervised clustering (Fig 6, A, data set 2). Two hundred
forty-two of the obtained DEGs could be linked to 346 DMRs
(Fig 6, B). Those target genes most likely mediating the
BBP-related asthma promotion should fulfill certain criteria (see
Fig E2 in this article’s Online Repository at www.jacionline.org
and data set 3). As already mentioned, BBP-induced hypermethy-
lation was correlated with increased airway inflammation, which
was alleviated by treatment with the DNA-demethylating agent
Aza. Therefore, in a first step, we concentrated on those DEGs
related to hypermethylated DMRs (201DEGs) located in function-
ally translating regulatory elements (promoter/enhancer; 33 DEGs
remaining). Because DNA hypermethylation is a key mechanism
to gene silencing, we focused only on those transcriptionally
repressed genes, leaving us with 13 potential candidates (data set
3). Among those, 3 genes were previously described to play a
role inTH2-driven allergic immunediseases andwere subsequently
evaluated in more detail.
Fatty acid desaturase 1 (Fads1) is an enzyme that regulates
desaturation of fatty acids and is involved in the synthesis of long-
chain polyunsaturated fatty acid. It has been shown that down-
regulation of the Fads gene is associated with lower
polyunsaturated fatty acid levels and atopic eczema.35 The second
gene, Fanconi anemia complementation group A (Fanca),
regulates the activity of regulatory T cells. Deletion of Fanca
leads to a decreased efficiency to suppress effector T-cell
function.36 Third, we focused on Zfpm1, also known as friend
of GATA protein 1 (Fog1), a gene that acts as a repressor of
GATA-3–mediated TH2 cell development.
37-39 Therefore
downregulation of Zfpm1 could promote a TH2-driven immune
response. Validation of our RNA-sequencing results by using
real-time PCR confirmed a reduced expression of all 3 genes in
CD41 T cells from 3-week-old offspring of BBP-exposed dams
compared with control animals (Fig 6, C). In contrast, in
BBP-exposed F0 mice expression of Fads1, Fanca, and Zfpm1
was not altered (Fig 6, C). Furthermore, downregulation of Fanca
and Zfpm1 was also seen in full-grown offspring of BBP-exposed
dams (8 to 12 weeks old), whereas the effect of maternal BBP
exposure on Fads1 expression in adult mice was not significant
(Fig 6, C). Aza treatment of BBP-treated pups not only alleviated
the asthma-promoting effect, as described earlier, but also
abrogated downregulation of Fanca and Zfpm1 in the mature F1
generation (Fig 6, D).To evaluate whether the potential mediators of phenotype
development identified in our mouse model might also play a
role in human subjects, we performed real-time PCR analysis in
whole-blood samples of 4-year-old children of the LINA cohort.
Interestingly, high urinary maternal MnBP concentrations
(ie, MnBP concentrations greater than the median) were
associated with a significant decrease in ZFPM1 expression in the
children (MWU:P5 .025; see Fig E3,A, in this article’s Online Re-
positoryatwww.jacionline.org) in accordancewithour observations
in the mouse model, no significant decrease of FADS1 or FANCA
expression in prenatally MnBP-exposed children was observed
(data not shown). Concomitant with a decrease in ZFPM1 expres-
sion, asthmaticchildrenshoweda significant increase inmethylation
at a CpG site (chromosome 16: 88564360, R 5 20.87, P 5 .001)
located in an intronic human enhancer region corresponding to the
region observed in mice, which also in human subjects appears to
regulate its host gene ZFPM1 (see Fig E3, B and C).Altered function of CD41 T cells in the offspring of
BBP-exposed mice
Both Fanca and Zfpm1 are described to play a crucial role in
T-cell differentiation and function.36,37 To investigate a possible ef-
fect of maternal BBP exposure on both of these end points in the
next generation, we isolated splenic CD41 effector T cells
from 8-week-old offspring and stimulated the cells with
anti-CD3/CD28 antibodies. Although proliferation of T cells was
not affected (data not shown), CD41 T cells from BBP-exposed
offspring appeared more activatable than T cells from nonexposed
control mice, as shown by expression of the activation marker
CD25 (Fig 7, A). Interestingly, we detected significantly more
IL-4–producing CD41 T cells in the F1 generation from exposed
mice, whereas the increased number of IL-13–producing
cells reached borderline significance and the number of IFN-
g–producing cells was unaffected (Fig 7, B). Furthermore, we
found a reduced number of forkhead box p3 (Foxp3)–positive
regulatory T cells in stimulated CD41CD251 T cells from
BBP-exposed offspring compared with cells derived from control
mice (Fig 7, C). However, the described differences did not
reach statistical significance. Furthermore, the frequency of
Foxp3-positive regulatory T cells in the blood and in
unstimulated splenocytes of BBP-exposed offspring was
not affected (see Fig E4 in this article’s Online Repository at
www.jacionline.org). Accordingly, the efficiency of CD41CD251
regulatory T cells to suppress responder T cells was slightly but not
significantly impaired by using cells from BBP-exposed mice
compared with regulatory T cells from control animals (Fig 7, D).Maternal BBP exposure affects airway inflammation
in the F2 generation
To investigate whether the asthma-promoting effect of peri-
natal BBP exposure persists up to the F2 generation, we mated
perinatally exposed female with nonexposed male mice and
induced an asthma-like phenotype in the F2 generation (Fig 2,C).
Surprisingly, exposure to BBP during pregnancy and breast-
feeding enhanced the eosinophilic airway inflammation (Fig 8,
A and B) and AHR (Fig 8, C) but did not alter OVA-specific
IgE levels in the F2 generation (Fig 8, D). Because treatment of
F2 pups with Aza reduced their increased airway inflammation
in relation to BBP exposure of their grandmother, an involvement
FIG 6. BBP-induced hypermethylation leads to downregulation of selected target genes.A,Heatmap displays
DEGs from pups of BBP-exposed dams versus control mice. B, Two hundred forty-two of 1338 DEGs in the
offspring from BBP-exposed dams can be linked to 346 DMRs. C, RNA expression of selected genes in
dams (n 5 5), pups, or adult mice (n >_ 6 from >_4 dams) was verified by using quantitative PCR. D, Mice
from BBP-exposed dams were treated with Aza, as described in the Methods section, and RNA expression
was measured in mature offspring (n >_ 6 from >_2 dams). Data are expressed as means 6 SEMs from at least
2 independent experiments. *P < .05, CON versus BBP. #P < .05, BBP versus BBP 1 Aza.
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promoting this immune response is highly probable (Fig 8, A
and C). However, we did not observe changes in DNA
methylation related to BBP exposure in F2 pups in Fads1, Fanca
(both promoters), or Zfpm1 DMRs (enhancer) identified in F1
pups, and these genes were not significantly differentially ex-
pressed (see Fig E5 in this article’s Online Repository at www.
jacionline.org).
DISCUSSION
The role of phthalate exposure in the increasing prevalence of
atopic diseases has been a topic of great interest in recent years.
However, from current studies, no clear conclusion can be drawn
about the role of phthalates in asthma development or about the
potential mechanisms involved.18 In the present study we showed
that higher concentrations of MnBP in maternal urine duringpregnancy were associated with an increased risk of asthma in
children up to age 6, whereas none of the other phthalate
metabolites analyzed were associated with this disease outcome.
These results are in line with findings of a recent study byWhyatt
et al,40 who found a positive association between the maternal
urine phthalate metabolites MnBP and MBzP and asthma risk
in children between the ages of 5 and 11,40 whereas other studies
only found such a correlation for MBzP but not MnBP.41 These
discrepancies might in part be due to differences in study size
but might also be related to regional differences in exposure
pattern to the different members of the phthalate family.
Interestingly, beyond the increased risk of asthma development
by MnBP, we also observed a link between maternal MnBP
concentrations and the risk for sensitization against inhalant
allergens in the children, suggesting involvement of an atopic
mechanism.
FIG 7. Altered function of CD41 T cells in offspring of BBP-exposed mice. A-C, Numbers of CD41CD251
T cells (Fig 7, A), percentages of cytokine-producing T cells (Fig 7, B), and Foxp31CD41CD251 T cells
(Fig 7, C) are shown. D, Efficiency of CD41CD251 regulatory T (Treg) cells to suppress proliferation of
responder T cells. Data are expressed as means 6 SEMs (n >_ 5 from 3 independent experiments). *P < .05.
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BBP,40 with MnBP being the major metabolite of BBP and ap-
pearing in larger quantities in urine compared with MBzP.31,42
Thus we investigated the effect of maternal BBP exposure on
the asthma-like phenotype in our murine transgenerational
model.
Applied BBP exposure concentrations were based on the
tolerable daily intake of BBP in human subjects of 0.5 mg/kg
body weight per day,43 which corresponds to an estimated uptake
of 0.48 to 0.6 mg BBP/kg body weight per day in our mouse ex-
periments (assuming 4-5 mL/d drinking water intake containing
3 mg/mL BBP). The resulting urinary MnBP concentrations in
our murine model were similar to those observed in highly
exposed mothers of the LINA cohort, suggesting that BBP
concentrations investigated here are representative for the real
exposure situation in human subjects.
Although prenatal and perinatal exposure to BBP increased
asthma severity in the offspring, exposure of adult mice did not
affect the allergic immune response, further corroborating the
notion that themost vulnerable time period for phthalate exposure
is during pregnancy and shortly after birth.18
Another interesting finding was the inability of the BBP
metabolites MnBP or MBzP to significantly increase
allergic airway inflammation in the offspring when applied
perinatally to the dams. These data point to a direct effect of
the parent compound BBP, even without biotransformation.
However, further insight into the BBP-mediated initial
molecular events in the dams or the fetus has to be explored in
future studies.There is growing evidence that prenatal and perinatal exposure
to diverse environmental chemicals might dysregulate the fetal or
neonatal epigenome, with potential consequences for diseases
manifesting in childhood.44 Because the asthma-promoting
effects by BBP in the present study were only detectable in the
offspring from exposed dams, we investigated the effects of
BBP on the epigenetic landscape. Previous studies already
showed an effect on DNA methylation by certain phthalates but
only based on targeted approaches restricted to preselected genes,
such as glucose transporter type 4 (Glut4) or proinflammatory cy-
tokines (TNF-a).45-47 In the current study we subjected samples
from our transgenerational mouse model to a genome-wide
evaluation of DNA methylation changes related to BBP. This
analysis was centered on the CD41 T-cell subset because these
cells have a central role in initiation and maintenance of the
allergic immune response.48Maternal BBP exposure led to global
dysregulation in DNA methylation in the offspring dominated by
DNA hypermethylation. In contrast to our findings, Wang et al45
described a phthalate-induced DNA hypomethylation to be
responsible for their observed increased asthma risk. However,
the study was based on methylation analysis of 21 selected genes
measured in human blood samples compared with our genome-
wide approach in a T-cell subset. Nevertheless, we also observed
phthalate-induced hypomethylation, such as in the promoter of
IL-4 (chromosome 11: 53620267-53620300) similar to what
has been described by Wang et al45 in human subjects (data set
1). Counteracting the global DNA hypermethylation in our study
by treating pups with the DNA methyltransferase inhibitor Aza
prevented BBP-related exacerbation of allergic airway
FIG 8. Maternal BBP exposure affects airway inflammation in the F2 generation. Total cell numbers in
bronchoalveolar lavage (BAL) fluid (A), airway inflammation (B), lung resistance (C), and OVA-specific IgE
levels (D) were examined in OVA-immunized F2 generation from prenatally BBP-exposed F1 dams
compared with control mice. Data are expressed as means 6 SEMs (n >_ 9 animals per group in the F2
offspring [from >_6 dams] from 6 independent experiments). *P < .05, OVA versus OVA 1 BBP. #P < .05,
OVA 1 BBP versus OVA 1 BBP 1 Aza.
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thylation and phenotype development.
Although recent findings indicated a wide variety of relation-
ships between DNA methylation and gene expression, high
promotor/enhancer methylation is classically associated with
low levels of gene expression.49,50 Therefore we focused on
significantly repressed genes with a promoter or enhancer
hypermethylation to further elucidate the functional translation
of the BBP associated hypermethylation. In the offspring of
BBP-exposed dams, we identified 13 genes fulfilling these
criteria, including 3 interesting candidates involved in immune
processes contributing to TH2 differentiation and therefore
resulting in a higher susceptibility to experience allergic
diseases.35,36,38 Considering the longitudinal stability of
differential RNA expression induced by maternal BBP
exposure from 3-week-old pups to the adult offspring, Fanca
and Zfpm1 appeared to be the most promising genes.
Characterizing the CD41 T-cell function from offspring
of BBP-exposed dams primarily revealed an increased
susceptibility for a TH2-driven immune response, as expected
from downregulation of the GATA-3 repressor Zfpm1.37 In
contrast, we could not show significant perturbations in
regulatory T-cell function, which would have been one
possible consequence of suppressed Fanca expression. Most
interestingly, we could corroborate a possible mediating role
of Zfpm1 in the phthalate effect by transferring the results of
the mouse model to our LINA cohort. ZFPM1 mRNA
expression was similarly decreased in children prenatallyexposed to high levels of MnBP. This decrease in gene
expression was correlated with an increase in ZFPM1
methylation in the same region identified as a differentially
methylated enhancer in our mouse model. The importance of
reduced expression of the GATA-3 repressor Zfpm1 by maternal
BBP exposure is supported by various studies therapeutically
targeting GATA-3 to attenuate the TH2-regulated inflammatory
response.51,52
To investigate whether the BBP-induced asthma-promoting
effect functions also in the absence of direct environmental
exposures through germline transmission of an altered epige-
nome,53 we characterized asthma severity in the grandmotherly
BBP-exposed F2 generation. Although we observed increased
airway inflammation, the phenotype compared with the F1
generation was slightly different, showing no effect on IgE serum
levels. Furthermore, neither DNA methylation nor RNA
expression of Fads1, Fanca, and Zfpm1 were affected in the F2
generation, suggesting that the underlying mechanisms of an
exacerbated asthma-like phenotype in the F1 and F2 generations
are different.
In summary, data from our study strongly suggest that early
exposure to specific phthalates increases susceptibility to the
development of allergic asthma in the offspring and even
contributes to airway inflammation in the F2 generation. The
asthma-promoting effect was mediated by epigenetic changes,
leading to altered expression of genes that play a crucial role in
immune regulation. Therefore chemical exposure of the devel-
oping immune system leads to an altered epigenetic prenatal
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later life but potentially also to other immune-regulated diseases.
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Key messages
d Maternal MnBP levels associate with an increased asthma
risk in children.
d In mice maternal exposure to BBP enhances airway
inflammation in the F1 and F2 generations through epige-
netic alterations.
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